Business & Economy
Stay informed on the latest news, stories, and analysis of the local business and economy in Oxford and Oxfordshire, including economic trends, key company appointments, and developments of local enterprises.
-
Oxford Biomedica gains MHRA approval for fourth manufacturing suite in Oxbox
Oxford Biomedica has announced MHRA approval for 4th GMP manufacturing suite within the Group’s new Oxbox manufacturing facility.
-
UK Gov contracts with Abingdon Health for COVID-19 rapid antibody tests
The UK government has entered into a contract with Abingdon Health, on behalf of the UK-Rapid Test Consortium, for the supply of COVID-19 rapid antibody tests.
-
OxLEP welcomes first Oxford to Cambridge Arc prospectus
LEPs, universities and local government leaders have unveiled a bold and ambitious vision in a new economic prospectus submitted to Government.
-
The Rooflight Company named West Oxfordshire’s Employer of the Year
The Rooflight Company, the Employee Owned high spec rooflight manufacturer, has been named West Oxfordshire’s Employer of the Year.
-
Oxford Nanopore partners with UK Gov on new generation COVID-19 test
The test is fully scalable and designed to enable both high-volume screening and rapid, local testing, and results can be obtained in under two hours.
-
Oxford-based The Native Antigen Company acquired by LGC
The Native Antigen Company, leading suppliers of high-quality infectious disease antigens and antibodies, has announced its acquisition by LGC.
-
Oxford Nanopore announces £48.4M in new capital to support ongoing innovation
Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital from new investors and existing shareholders in EMEA, US and Asia.
-
Circassia Pharmaceuticals to transfer respiratory medicine rights AstraZeneca
Circassia Pharmaceuticals has announced it intends to terminate its U.S. commercial rights to Tudorza® and Duaklir® and transfer the assets to AstraZeneca.
-
Oxford Biomedica joins COVID-19 vaccine development consortium
Oxford Biomedica has joined a consortium led by the Jenner Institute, Oxford University, to rapidly develop, scale-up and manufacture a potential vaccine candidate for COVID-19
-
The Oxford to Cambridge Expressway: An overview
The Oxford to Cambridge Expressway is a proposed grade-separated dual carriageway between Oxford and Cambridge via (or near) Milton Keynes.
-
Circassia announces business update for 31 December 2019
Oxford-based Circassia Pharmaceuticals has announced a business update including a trading update for the year ended 31 December 2019.
-
Oxford MedTech business OrganOx receives £4.6m investment from BGF
Oxford MedTech business, OrganOx has announced that it has received a £4.6m investment for its Unique human liver support system technology from BGF and active investor in growing businesses.
-
Oxford Nanopore Technologies raises £109.5m in investment and share sales
Oxford Nanopore Technologies raises £109.5m in investment and share sales with £29.3m of new capital and £80.2m from sale of secondary shares.
-
The Oxford-Cambridge Arc – Everything you need to know
The Oxford-Cambridge Arc is of vital economic importance in the UK and is home to leading international universities and science and technology companies.
-
Are unelected bodies deciding Oxfordshire’s future?
Independent group publishes a report highlighting concerns about influential role unelected bodies have in proposals for future development in Oxfordshire.
-
Oxford Metrics announces preliminary results to 30 Sept 2019
Oxford Metrics has announced preliminary results for the financial year ended 30 September 2019 with Group Revenue up 11.76% to £35.3m and adjusted profit before tax up 5.7% to £5.5m